Resistin Impairs Insulin-Evoked Vasodilation
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Since vascular dysfunction is a main trait of obese subjects, in the present study we evaluated the vascular impact of resistin, a recently discovered hormone markedly increased in obesity. RESEARCH DESIGN AND METHODS—We performed our analysis on aortic and mesenteric segments from young and old C57BL/6 mice and on cultured endothelial cells. Resistin-induced vascular effect was evaluated in vitro and in vivo. Molecular analyses were performed by immunoprecipitation and Western blotting. RESULTS—Recombinant murine resistin did not induce changes in either basal vascular tone or phenylephrine-induced vascular contraction. In contrast, both in vivo and in vitro administration of resistin significantly impaired dose-dependent insulin-evoked vasodilation by reducing endothelial nitric oxide synthase (eNOS) enzymatic activity. This effect of resistin was selective for insulin vascular action, since vasodilatation induced by increasing doses of acetylcholine or nitroglycerin was not influenced by the hormone. Molecular analysis of endothelial cells further detailed resistin-induced vascular resistance by showing impairment of insulin-evoked AKT and eNOS phosphorylations after exposure to resistin. Even this latter abnormality is selective of insulin signaling since AKT/eNOS phosphorylations are normally activated during acetylcholine stimulation. More important, the resistin-induced endothelial dysfunction depends on resistin's ability to alter insulin receptor substrate (IRS)-1 tyrosine/serine phosphorylation and its consequent interaction with phosphatidylinositol 3-kinase. CONCLUSIONS—Our results demonstrate that resistin is able to induce a selective vascular insulin resistance-impairing endothelial IRS-1 signaling pathway that leads to eNOS activation and vasodilation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 1×
“An increased serine phosphorylation of IRS-1 may make this form of IRS a “poor” insulin receptor substrate (44) or result in its dissociation from the insulin receptor and trigger proteasome-dependent degradation (45).”
BackgroundSignaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Zeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726 · cited 1×
“It has been clearly demonstrated that the vasodilation evoked by insulin is mediated by NO released from the endothelium by eNOS (33,34), and we observed that resistin decreased eNOS enzymatic activity.”
Background
Cited by
Resistin: functional roles and therapeutic considerations for cardiovascular disease
Jamaluddin, M. S., Weakley, S. M., Yao, Q., & Chen, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01369.x · Cited by 536
Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B. J., Withers, S. B., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 272
Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels
Yamawaki, H., Tsubaki, N., Mukohda, M., Okada, M., & Hara, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.053 · Cited by 252
Loche, E., Blackmore, H. L., Carpenter, A. A., Beeson, J. H., Pinnock, A., Ashmore, T. J., Aiken, C. E., de Almeida-Faria, J., Schoonejans, J. M., Giussani, D. A., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy082 · Cited by 105
“However, an interplay between insulin and resistin may contribute to the increase in blood pressure in the OO group.(55) Thus, the double exposure to an obesogenic diet during these two periods of life would increase their vulnerability to metabolic dysfunction, as previously reported.”
Resultp66Shc-induced redox changes drive endothelial insulin resistance
Paneni, F., Costantino, S., & Cosentino, F. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.07.027 · Cited by 38
“Contraction to phenylephrine (10 6 mol/L) and endotheliumdependent relaxation to insulin (10 9e10 5 mol/L) were assessed in aortic rings, as previously described [13].”
Method
Metadata
- Authors
- Gentile, M. T., Vecchione, C., Marino, G., Aretini, A., Di Pardo, A., Antenucci, G., Maffei, A., Cifelli, G., Iorio, L., Landolfi, A., Frati, G., & Lembo, G.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-03-01
- Volume
- 57
- Issue
- 3
- Pages
- 577-583
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2124343304
- Cited by
- 65
- References
- 4
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.